207 related articles for article (PubMed ID: 8542903)
1. Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection.
Giammarile F; Lumbroso J; Ricard M; Aubert B; Hartmann O; Schlumberger M; Parmentier C
Eur J Nucl Med; 1995 Oct; 22(10):1180-3. PubMed ID: 8542903
[TBL] [Abstract][Full Text] [Related]
2. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
3. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
[TBL] [Abstract][Full Text] [Related]
4. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
[TBL] [Abstract][Full Text] [Related]
5. [Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma].
Müller-Gärtner HW; Erttmann R; Helmke K
Nuklearmedizin; 1985 Dec; 24(5-6):222-6. PubMed ID: 3912731
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D
Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
[TBL] [Abstract][Full Text] [Related]
7. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
Shulkin BL; Shapiro B; Hutchinson RJ
J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the utility of
Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
[TBL] [Abstract][Full Text] [Related]
9. Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.
Lastoria S; Maurea S; Caracò C; Vergara E; Maurelli L; Indolfi P; Casale F; di Tullio MT; Salvatore M
Eur J Nucl Med; 1993 Dec; 20(12):1161-7. PubMed ID: 8299651
[TBL] [Abstract][Full Text] [Related]
10. The impact of 123I-meta-iodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma.
Abrahamsen J; Lyck B; Helgestad J; Frederiksen PB
Acta Oncol; 1995; 34(4):505-10. PubMed ID: 7605659
[TBL] [Abstract][Full Text] [Related]
11. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
Schwarz KB; Driver I; Lewis IJ; Taylor RE
Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302
[TBL] [Abstract][Full Text] [Related]
12. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.
Geatti O; Shapiro B; Sisson JC; Hutchinson RJ; Mallette S; Eyre P; Beierwaltes WH
J Nucl Med; 1985 Jul; 26(7):736-42. PubMed ID: 4009283
[TBL] [Abstract][Full Text] [Related]
13. Meta-iodobenzylguanidine in children.
Gelfand MJ
Semin Nucl Med; 1993 Jul; 23(3):231-42. PubMed ID: 8378796
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma].
Guerra P
Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
Parisi MT; Greene MK; Dykes TM; Moraldo TV; Sandler ED; Hattner RS
Invest Radiol; 1992 Oct; 27(10):768-73. PubMed ID: 1399431
[TBL] [Abstract][Full Text] [Related]
16. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
[TBL] [Abstract][Full Text] [Related]
17. Immunoscintigraphic imaging of mIBG-negative metastases in neuroblastoma.
Berthold F; Waters W; Sieverts H; Linden A
Am J Pediatr Hematol Oncol; 1990; 12(1):61-2. PubMed ID: 2178460
[TBL] [Abstract][Full Text] [Related]
18. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
Sautter-Bihl ML; Bihl H; Heinze HG
Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.
Parisi MT; Matthay KK; Huberty JP; Hattner RS
Radiology; 1992 Aug; 184(2):463-7. PubMed ID: 1620849
[TBL] [Abstract][Full Text] [Related]
20. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
